Skip to main content

Good evening, here are the coronavirus updates you need to know tonight.

Top headlines:

  1. Under a new deal, Novavax could produce vaccines in Montreal, which would make it the first company to manufacture the shots in Canada
  2. An Ontario doctor has been fired because of his public criticism of the provincial government’s handling of the COVID-19 pandemic
  3. A mutation of the British coronavirus variant has been discovered, raising fears it could be resistant to vaccines

In the last 7 days, 29,402 cases were reported, down 21 per cent from the previous 7 days. There were 810 deaths announced, down 29 per cent over the same period. At least 3,457 people are being treated in hospitals and 961,582 others are considered recovered.

About 86 per cent of the 1,143,341 doses of vaccine distributed to provinces have been administered. That’s 2.6 doses for every 100 people in Canada.


Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and charts Lockdown rules and reopeningCanada’s vaccine distribution planDeveloping/approved vaccinesPfizer’s vaccine, explained Essential resources


Photo of the day

A woman plays the violin as a tribute to Captain Tom Moore in London's Piccadilly Circus today. The British Second World War veteran, who walked into the hearts of a nation in lockdown as he shuffled up and down his garden to raise money for health care workers, has died after testing positive for COVID-19. Capt. Moore was 100.Aaron Chown/The Associated Press


Coronavirus in Canada


In Ottawa, Prime Minister Justin Trudeau announced the government signed a tentative deal with Novavax to produce COVID-19 vaccines in Montreal – however, doses of those vaccines will not be available for several months.

  • The agreement won’t change the pressure on the government to get vaccine supply into the country as the company first has to finish building a new facility and have it certified to make the vaccines.
  • Last Friday, Novavax applied for regulatory approval, but is still finishing its clinical trials and doesn’t expect to have final data for a month or two at least. “At the end of the year we will be in a position to be producing vaccines,” said Industry Minister François-Philippe Champagne.
  • Canada relies entirely on Europe for its COVID-19 vaccine supply, a challenge as the European Union imposes new export controls on vaccines to protect its own deliveries.

COVID-19 travel: A new poll shows 86 per cent of Canadians support the new travel restrictions imposed by the federal government.

Inconsistent testing: Testing for the variants differs considerably from province to province.


Coronavirus around the world


Coronavirus and business

The federal government is extending $375-million in credit to Sunwing, the Toronto-based airliner, days after it agreed to suspend flights to Mexico and the Caribbean until the end of April.

Also today: LGBTQ businesses hit hard by COVID-19 pandemic look for shifts in federal programs.

And: Pfizer forecasts about $15-billion in sales of its COVID-19 vaccine in 2021.


Globe opinion

  • Matthew Romanada: “It was #notmycat but my new found feline friend who visited through the window made isolating during the pandemic kind of meow-right.”
  • Gary Mason: People are sick and tired of this bloody disease, but they’ve also had it with the incompetence of our political leaders, not to mention their shocking lack of spine.

More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.